Mazabraud Yann 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Mazabraud Yann
EVP, Head of International
Transactions
- Award
Restricted Stock Units
2025-02-14+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2025-02-16+5,500→ 40,370 total - Award
Stock Options (Right to Buy)
2025-02-14+60,000→ 60,000 totalExercise: $56.69Exp: 2035-02-13→ Common Stock (60,000 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-16−5,500→ 16,500 total→ Common Stock (5,500 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.
- [F3]The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
- [F4]The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.